Cas:420-03-1 fluoromethanol manufacturer & supplier

We serve Chemical Name:fluoromethanol CAS:420-03-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

fluoromethanol

Chemical Name:fluoromethanol
CAS.NO:420-03-1
Synonyms:Fluor-methanol;fluorohydroximethylene;fluoromethyl alcohol
Molecular Formula:CH3FO
Molecular Weight:50.03230
HS Code:2905590090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:20.23000
Exact Mass:50.01680
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Fluor-methanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,fluoromethyl alcohol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Fluor-methanol Use and application,fluorohydroximethylene technical grade,usp/ep/jp grade.


Related News: The ban will be in place for up to 14 days, and is aimed at helping contain the spread of the Wuhan coronavirus. So far, there have been no confirmed coronavirus cases in New Zealand or any South Pacific island. fluoromethanol manufacturer ��With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.�� fluoromethanol supplier Ultimately there’s likely a broad mix of social, cultural and economic drivers at play, suggested Lona Sandon, program director of the Department of Clinical Nutrition in the School of Health Professions at the UT Southwestern Medical Center in Dallas. She was not part of the research. fluoromethanol vendor Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. fluoromethanol factory ��With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.��